ApoE alleles, depression and positive affect in multiple sclerosis

Area of Science:

• Neurogenetics
• Psychiatry
• Neurology

Background:

• Apolipoprotein E (ApoE) alleles are linked to depressive disorders, with epsilon4 increasing risk and epsilon2 offering protection.
• Depression is prevalent in multiple sclerosis (MS), but the influence of ApoE alleles remains unclear.

Purpose of the Study:

• To investigate the association between ApoE alleles and depression symptoms in MS patients.
• To determine if ApoE epsilon4 allele increases depression risk and if ApoE epsilon2 allele offers protection.

Main Methods:

• Analysis of ApoE epsilon2 and epsilon4 allele carriers among 101 MS patients from the Sonya Slifka Longitudinal Multiple Sclerosis Study.
• Hierarchical linear regression to assess the impact of ApoE alleles on depressed mood and positive affect, controlling for demographics, disease duration, and disability.

Main Results:

• ApoE epsilon2 carriers showed significantly increased positive affect (R2Delta=0.05, P=0.02).
• ApoE epsilon2 was associated with decreased depressive symptom severity (R2Delta=0.03, P=0.06), nearing statistical significance.
• ApoE epsilon4 did not significantly predict depression status.

Conclusions:

• The ApoE epsilon2 allele appears to be protective against depressive symptoms in MS patients.
• Findings align with existing research linking ApoE epsilon2 to reduced depression incidence in psychiatric populations.
• Further research is needed to fully elucidate the role of ApoE genotypes in MS-related depression.